| ncRNA_id |
ncRNA_name |
drug_id |
drug_name
|
cancer |
drug
response |
PMID |
details |
| MI0000342 |
miR-200b |
DB00441 (APRD00201) |
Gemcitabine |
cholangiocarcinoma |
sensitive |
16762633 |
more... |
| MI0000737 |
miR-200a |
DB00997 (APRD00185, DB05331, DB05847) |
Adriamycin |
breast cancer |
resistant |
18971180 |
more... |
| MI0000342 |
miR-200b |
DB00997 (APRD00185, DB05331, DB05847) |
Adriamycin |
breast cancer |
resistant |
18971180 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Adriamycin |
breast cancer |
resistant |
18971180 |
more... |
| MI0000650 |
miR-200c |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
endometrial cancer |
sensitive |
19435871 |
more... |
| MI0000650 |
miR-200c |
DB03010 (EXPT01349) |
Epothilone B |
endometrial cancer |
sensitive |
19435871 |
more... |
| MI0000650 |
miR-200c |
DB00541 (APRD00495) |
Vincristine |
endometrial cancer |
sensitive |
19435871 |
more... |
| MI0000342 |
miR-200b |
DB00441 (APRD00201) |
Gemcitabine |
pancreatic cancer |
sensitive |
19654291 |
more... |
| MI0000650 |
miR-200c |
DB00441 (APRD00201) |
Gemcitabine |
pancreatic cancer |
sensitive |
19654291 |
more... |
| NA |
miR-200 |
DB00002 (BTD00071, BIOD00071) |
Cetuximab |
bladder cancer |
sensitive |
19671845 |
more... |
| MI0000342 |
miR-200b |
DB00997 (APRD00185, DB05331, DB05847) |
Doxorubicin |
breast cancer |
sensitive |
19839049 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Doxorubicin |
breast cancer |
sensitive |
19839049 |
more... |
| MI0000342 |
miR-200b |
DB01248 (APRD00932) |
Docetaxel |
lung adenocarcinoma |
resistant |
19900214 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
lung non-small cell carcinoma |
sensitive |
20696752 |
more... |
| MI0000650 |
miR-200c |
DB00002 (BTD00071, BIOD00071) |
Cetuximab |
lung non-small cell carcinoma |
sensitive |
20696752 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
stomach cancer |
sensitive |
21114921 |
more... |
| MI0000650 |
miR-200c |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
stomach cancer |
sensitive |
21114921 |
more... |
| MI0000650 |
miR-200c |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
stomach cancer |
sensitive |
21114921 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Adriamycin |
stomach cancer |
sensitive |
21114921 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
esophageal cancer |
resistant |
21248297 |
more... |
| MI0000737 |
miR-200a |
DB12385 |
10-hydroxycamptothecin |
stomach cancer |
resistant |
21293479 |
more... |
| MI0000342 |
miR-200b |
DB12385 |
10-hydroxycamptothecin |
stomach cancer |
resistant |
21293479 |
more... |
| MI0000650 |
miR-200c |
DB12385 |
10-hydroxycamptothecin |
stomach cancer |
resistant |
21293479 |
more... |
| MI0000342 |
miR-200b |
DB00515 (APRD00359) |
Cisplatin |
endometrial cancer |
resistant |
22194984 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
endometrial cancer |
resistant |
22194984 |
more... |
| MI0000342 |
miR-200b |
DB00515 (APRD00359) |
Cisplatin |
tongue cancer |
resistant |
21725369 |
more... |
| MI0000342 |
miR-200b |
DB00541 (APRD00495) |
Vincristine |
gastric adenocarcinoma |
resistant |
21993663 |
more... |
| MI0000650 |
miR-200c |
DB00541 (APRD00495) |
Vincristine |
gastric adenocarcinoma |
resistant |
21993663 |
more... |
| MI0000342 |
miR-200b |
DB00515 (APRD00359) |
Cisplatin |
gastric adenocarcinoma |
resistant |
21993663 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
gastric adenocarcinoma |
resistant |
21993663 |
more... |
| MI0000342 |
miR-200b |
DB00541 (APRD00495) |
Vincristine |
lung cancer |
resistant |
21993663 |
more... |
| MI0000650 |
miR-200c |
DB00541 (APRD00495) |
Vincristine |
lung cancer |
resistant |
21993663 |
more... |
| MI0000342 |
miR-200b |
DB00515 (APRD00359) |
Cisplatin |
lung cancer |
resistant |
21993663 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
lung cancer |
resistant |
21993663 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
esophagus adenocarcinoma |
resistant |
22015043 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Doxorubicin |
breast cancer |
resistant |
22101791 |
more... |
| MI0000342 |
miR-200b |
DB01248 (APRD00932) |
Docetaxel |
lung adenocarcinoma |
sensitive |
22139708 |
more... |
| MI0000650 |
miR-200c |
DB01248 (APRD00932) |
Docetaxel |
prostate cancer |
resistant |
23041061 |
more... |
| MI0000650 |
miR-200c |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
ovarian cancer |
sensitive |
23074172 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Doxorubicin |
breast cancer |
resistant |
23209748 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Doxorubicin |
breast cancer |
resistant |
23546450 |
more... |
| MI0000737 |
miR-200a |
DB11672 |
Curcumin |
hepatocellular carcinoma |
resistant |
23760980 |
more... |
| MI0000342 |
miR-200b |
DB11672 |
Curcumin |
hepatocellular carcinoma |
resistant |
23760980 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Adriamycin |
esophageal cancer |
sensitive |
23838916 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
esophageal cancer |
sensitive |
23838916 |
more... |
| MI0000650 |
miR-200c |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
esophageal cancer |
sensitive |
23838916 |
more... |
| MI0000650 |
miR-200c |
DB01248 (APRD00932) |
Docetaxel |
esophageal cancer |
sensitive |
23838916 |
more... |
| MI0000650 |
miR-200c |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
breast cancer |
sensitive |
24039897 |
more... |
| MI0000342 |
miR-200b |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
cholangiocarcinoma |
sensitive |
24169343 |
more... |
| MI0000650 |
miR-200c |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
cholangiocarcinoma |
sensitive |
24169343 |
more... |
| MI0000342 |
miR-200b |
DB00530 (APRD00951) |
Erlotinib |
lung adenocarcinoma |
sensitive |
24199791 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
stomach cancer |
sensitive |
23821457 |
more... |
| MI0000342 |
miR-200b |
DB01248 (APRD00932) |
Docetaxel |
prostate cancer |
sensitive |
24317363 |
more... |
| MI0000650 |
miR-200c |
DB00072 (BTD00098, BIOD00098) |
Trastuzumab |
breast cancer |
sensitive |
24615544 |
more... |
| MI0000342 |
miR-200b |
DB00515 (APRD00359) |
Cisplatin |
lung small cell carcinoma |
sensitive |
24769353 |
more... |
| MI0000342 |
miR-200b |
DB01248 (APRD00932) |
Docetaxel |
lung adenocarcinoma |
sensitive |
24830600 |
more... |
| NA |
miR-200 |
DB00530 (APRD00951) |
Erlotinib |
cancer |
sensitive |
24830724 |
more... |
| MI0000342 |
miR-200b |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Taxol |
melanoma |
sensitive |
25138213 |
more... |
| MI0000342 |
miR-200b |
NA |
Celastrol |
melanoma |
sensitive |
25138213 |
more... |
| MI0000650 |
miR-200c |
DB00398 (APRD01304, DB07438) |
Sorafenib |
renal cell carcinoma |
sensitive |
25150313 |
more... |
| MI0000650 |
miR-200c |
DB00619 (APRD01028, EXPT02967, DB03261) |
Imatinib |
renal cell carcinoma |
sensitive |
25150313 |
more... |
| MI0000650 |
miR-200c |
DB00317 (APRD00997, DB07998) |
Gefitinib |
lung non-small cell carcinoma |
sensitive |
25277203 |
more... |
| MIMAT0000318 |
miR-200b-3p |
DB00515 (APRD00359) |
Cisplatin |
esophageal cancer |
resistant |
25356050 |
more... |
| MIMAT0004571 |
miR-200b-5p |
DB00515 (APRD00359) |
Cisplatin |
esophageal cancer |
resistant |
25356050 |
more... |
| MIMAT0000682 |
miR-200a-3p |
DB00515 (APRD00359) |
Cisplatin |
esophageal cancer |
resistant |
25356050 |
more... |
| MI0000650 |
miR-200c |
DB00997 (APRD00185, DB05331, DB05847) |
Doxorubicin |
breast cancer |
resistant |
25451164 |
more... |
| MIMAT0000617 |
miR-200c-3p |
DB12257 |
Platinum |
ovarian cancer |
resistant |
25872328 |
more... |
| MI0000737 |
miR-200a |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
ovarian cancer |
sensitive |
25997962 |
more... |
| MI0000650 |
miR-200c |
DB00958 (APRD00466) |
Carboplatin |
ovarian carcinoma |
resistant |
26025631 |
more... |
| MI0000650 |
miR-200c |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
ovarian carcinoma |
resistant |
26025631 |
more... |
| MI0000737 |
miR-200a |
DB00317 (APRD00997, DB07998) |
Gefitinib |
lung non-small cell carcinoma |
sensitive |
26184032 |
more... |
| MIMAT0000617 |
miR-200c-3p |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
lung adenocarcinoma |
resistant |
26323677 |
more... |
| NA |
miR-200 |
DB00531 (APRD00408) |
Cyclophosphamide |
breast cancer |
sensitive |
26560033 |
more... |
| NA |
miR-200 |
DB09079 |
Nintedanib |
lung non-small cell carcinoma |
sensitive |
26783187 |
more... |
| MI0000650 |
miR-200c |
DB00563 (APRD00353) |
Methotrexate |
lung cancer |
sensitive |
27432063 |
more... |
| MI0000650 |
miR-200c |
DB08865 (DB08700) |
Crizotinib |
lung cancer |
sensitive |
27666124 |
more... |
| MI0000650 |
miR-200c |
DB00317 (APRD00997, DB07998) |
Gefitinib |
lung non-small cell carcinoma |
sensitive |
27930974 |
more... |
| MIMAT0000682 |
miR-200a-3p |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
hepatocellular carcinoma |
resistant |
28496200 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
stomach cancer |
sensitive |
28534959 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
osteosarcoma |
sensitive |
29051585 |
more... |
| MI0000650 |
miR-200c |
DB00544 (APRD00516, EXPT03204) |
Fluorouracil |
colorectal cancer |
sensitive |
28411308 |
more... |
| MI0000650 |
miR-200c |
DB00563 (APRD00353) |
Methotrexate |
osteosarcoma |
resistant |
29170124 |
more... |
| MI0000650 |
miR-200c |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
lung cancer |
sensitive |
29219949 |
more... |
| MI0000737 |
miR-200a |
DB00441 (APRD00201) |
Gemcitabine |
breast cancer |
sensitive |
29329575 |
more... |
| MIMAT0000617 |
miR-200c-3p |
DB01229 (APRD00259, DB05261, DB05927, DB05526, DB05281) |
Paclitaxel |
breast cancer |
resistant |
30272330 |
more... |
| MI0000342 |
miR-200b |
DB00441 (APRD00201) |
Gemcitabine |
pancreatic carcinoma |
sensitive |
30628651 |
more... |
| MI0000342 |
miR-200b |
DB00515 (APRD00359) |
Cisplatin |
ovarian cancer |
resistant |
30675199 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
ovarian cancer |
resistant |
30675199 |
more... |
| MI0000737 |
miR-200a |
DB01248 (APRD00932) |
Docetaxel |
breast cancer |
resistant |
30786836 |
more... |
| MI0000650 |
miR-200c |
DB00515 (APRD00359) |
Cisplatin |
stomach cancer |
resistant |
31289483 |
more... |